This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Liver Cancer or Hepatocellular Cancer
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial is studying how well giving oxaliplatin and capecitabine together works in treating patients with liver cancer.

Provided treatments

  • Drug: Oxaliplatin
  • Drug: Capecitabine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03026803. The sponsor of the trial is City of Hope Medical Center and it is looking for 4 volunteers for the current phase.
Official trial title:
A Phase II Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer